Taking a step forward in oncologic PET/CT imaging
A new positron emission tomography (PET) scanner at Gundersen Health System is helping provide more accurate diagnoses, staging and surveillance of cancer.
Gundersen upgraded its PET/CT scanner in mid-June with the General Electric Molecular Imaging Digital Ready PET/CT scanner with Q.Clear technology. The new scanner offers much-improved image quality and accuracy, giving Gundersen radiologists more confidence to say whether cancer is present in a given location.
Brian Manske, MD
"The benefit of this PET scanner is that it is able to detect smaller lesions, and see them more clearly, which is very important in the staging of cancers," states Jay Bjorklund, clinical manager, Nuclear Medicine.
Gundersen radiologist and section chief of Nuclear Medicine, Brian Manske, MD, points out that the new technology will help clinicians across the cancer care continuum. In addition to detecting cancer, PET/CT can accurately determine whether cancer has spread, check if treatment is working and find cancer recurrence.
"It is a very valuable test for directing therapy," Dr. Manske notes.
By having a more accurate and reliable tool to confirm that a change in treatment is needed, your patients will benefit, as well.
"For example, PET/CT can help us determine if chemotherapy is working in fewer cycles, saving patients time, money and unnecessary treatments," says Dr. Manske.
For consultations or to schedule a patient, call Gundersen MedLink at (608) 775-5465.